Module-based prediction approach for robust inter-study predictions in microarray data

Bioinformatics

Volumn 26, Issue 20, 2010, Pages 2586-2593

  Mi, Zhibao ^a,b   Shen, Kui ^c,d   Song, Nan ^d   Cheng, Chunrong ^b   Song, Chi ^b   Kaminski, Naftali ^c   Tseng, George C ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Precision Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGY; CLUSTER ANALYSIS; DNA MICROARRAY; FACTUAL DATABASE; GENE EXPRESSION PROFILING; METHODOLOGY;

CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 77957786147     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq472     Document Type: Article

References (49)

1. Beer,D.G. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med., 8, 816-824.
2. Bhanot,G. et al. (2005) Robust diagnosis of non-Hodgkin lymphoma phenotypes validated on gene expression data from different laboratories. Genome Inform., 16, 233-244.
3. Bhattacharjee,A. et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA, 98, 13790-13795.
4. Bloom,G. et al. (2004) Multi-platform, multi-site, microarray-based human tumor classification. Am. J. Pathol., 164, 9-16.
5. Bosotti,R. et al. (2007) Cross platform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics, 8 (Suppl. 1), S5.
6. Bussey,K.J. et al. (2003) MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol., 4, R27.
7. Cheadle,C. et al. (2007) A rapid method for microarray cross platform comparisons using gene expression signatures. Mol. Cell Probes, 21, 35-46.
8. Cheng,C. et al. (2009) Ratio adjustment and calibration scheme for gene-wise normalization to enhance microarray inter-study prediction. Bioinformatics, 25, 1655-1661.
9. Cristianini,N. and Shawe-Taylor,J. (2000) An Introduction to Support Vector Machines and Other Kernel-Based Learning Methods. Cambridge University Press, New York.
10. Dasarathy,B. (1991) Nearest Neighbor (NN) Norms: Nn Pattern Classification Techniques (Unknown Binding). IEEE Computer Society Press Tutorial.
11. Dhanasekaran,S.M. et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature, 412, 822-826.
12. Dobbin,K. and Simon,R. (2005) Sample size determination in microarray experiments for class comparison and prognostic classification. Biostatistics, 6, 27-38.
13. Dobbin,K.K. et al. (2008) How large a training set is needed to develop a classifier for microarray data? Clin. Cancer Res., 14, 108-114.
14. Ein-Dor,L. et al. (2005) Outcome signature genes in breast cancer: is there a unique set? Bioinformatics, 21, 171-178.
15. Garber,M.E. et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA, 98, 13784-13789.
16. Guyon,I. et al. (2002) Gene selection for cancer classification using support vector machines. Mach. Learn., 46, 389-422.
17. Hartigan,J.A. and Wong,M.A. (1979) A K-means clustering algorithm. Appl. Stat.,28, 100-108.
18. Huang,E. et al. (2003) Gene expression predictors of breast cancer outcomes. Lancet, 361, 1590-1596.
19. Irizarry,R.A. et al. (2005) Multiple-laboratory comparison of microarray platforms. Nat. Methods, 2, 345-350.
20. Kuhn,A. et al. (2008) Cross-species and cross-platform gene expression studies with the Bioconductor-compliant R package annotationTools. BMC Bioinformatics, 9, 26.
21. Lai,C. et al. (2006) A comparison of univariate and multivariate gene selection techniques for classification of cancer datasets. BMC Bioinformatics, 7, 235.
22. Luo,J. et al. (2001) Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res., 61, 4683-4688.
23. Mardia,K. et al. (1979) Multivariate Analysis. Academic Press, London.
24. Nilsson,B. et al. (2006) Cross-platform classification in microarray-based leukemia diagnostics. Haematologica, 91, 821-824.
25. Park,M.Y. et al. (2007) Averaged gene expressions for regression. Biostatistics, 8, 212-227.
26. Park,P.J. et al. (2004) Current issues for DNAmicroarrays: platform comparison, double linear amplification, and universal RNA reference. J. Biotechnol., 112, 225-245.
27. Pittman,J. et al. (2004) Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc. Natl Acad. Sci. USA, 101, 8431-8436.
28. Potti,A. etal. (2006)Agenomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N. Engl. J. Med., 355, 570-580.
29. Pusztai,L. and Leyland-Jones,B. (2008) Promises and caveats of in silico biomarker discovery. Br. J. Cancer, 99, 385-386.
30. Ramaswamy,S. et al. (2003) Amolecular signature of metastasis in primary solid tumors. Nat. Genet., 33, 49-54.
31. Segal,E. et al. (2004)Amodule map showing conditional activity of expression modules in cancer. Nat. Genet., 36, 1090-1098.
32. Shi,L. et al. (2005) Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinformatics, 6 (Suppl. 2), S12.
33. Shi,L. et al. (2004) QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies. Expert Rev. Mol. Diagn., 4, 761-777.
34. Sorlie,T. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA, 98, 10869-10874.
35. Spang,R. et al. (2002) Prediction and uncertainty in the analysis of gene expression profiles. In Silico Biol., 2, 369-381.
36. Tamayo,P. et al. (2007) Metagene projection for cross-platform, cross-species characterization of global transcriptional states. Proc. Natl Acad. Sci. USA, 104, 5959-5964.
37. Tan,P.K. et al. (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res., 31, 5676-5684.
38. Thalamuthu,A. et al. (2006) Evaluation and comparison of gene clustering methods in microarray analysis. Bioinformatics, 22, 2405-2412.
39. Tibshirani,R. et al. (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl Acad. Sci. USA, 99, 6567-6572.
40. Tseng,G.C. (2007) Penalized and weighted K-means for clustering with scattered objects and prior information in high-throughput biological data. Bioinformatics, 23, 2247-2255.
41. Tseng,G.C. and Wong,W.H. (2005) Tight clustering: a resampling-based approach for identifying stable and tight patterns in data. Biometrics, 61, 10-16.
42. van't Veer,L.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
43. van Vliet,M.H. et al. (2007) Module-based outcome prediction using breast cancer compendia. PLoS ONE, 2, e1047.
44. Welsh,J.B. et al. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 61, 5974-5978.
45. West,M. et al. (2001) Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl Acad. Sci. USA, 98, 11462-11467.
46. West,M. et al. (2006) Embracing the complexity of genomic data for personalized medicine. Genome Res., 16, 559-566.
47. Wong,D.J. et al. (2008) Revealing targeted therapy for human cancer by gene module maps. Cancer Res., 68, 369-378.
48. Yu,Y.P. et al. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol., 22, 2790-2799.
49. Zhang,X. et al. (2006) Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics, 7, 197.